These 2 ASX 200 shares just got big upgrades from top brokers

The brokers believe both ASX 200 shares are undervalued at current levels.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Two S&P/ASX 200 Index (ASX: XJO) shares just received some sizeable upgrades from leading brokers.

Health and safety products company Ansell Ltd (ASX: ANN) closed on Monday trading for $23.89 a share.

A number of brokers are forecasting a significant potential uplift from here, according to The Australian.

Jeffries is among the most bullish on the ASX 200 share. The broker's analysts raised the Ansell stock to a buy rating with a price target of $30.85 a share. That's more than 29% above Monday's closing price of $23.89.

Ansell shares are up 11.1% today, currently trading for $26.53 a share.

The second ASX 200 share receiving an upgraded outlook is agribusiness Elders Ltd (ASX: ELD).

Elders stock was raised to an add rating by Morgans Financial with a price target of $9 a share. That represents a potential 21% upside from Monday's close of $7.43.

Elders shares are up 5.7% today, currently trading for $7.85 per share.

Here's what's been happening with the two upgraded ASX 200 shares.

Graincorp share price farming asx share price rise represented by rejoicing farmer in field

Image source: Getty Images

ASX 200 shares tipped for outsized gains

Turning to Elders first, the ASX 200 share had an absolute horror day yesterday, with the share price crashing 24.4% by Monday's closing bell.

This followed on a disappointing trading update that came in significantly below consensus expectations.

The company's trading performance has been hampered by uncooperative weather conditions and lower-than-expected sheep and cattle prices. This saw management dial down full-year earnings estimates, now expected to be around 18% to 30% lower than the prior year.

Turning back the clock to Friday prior to the update's release, the Elders share price closed at $9.83. Meaning the upgrade from Morgans Financial really values the stock at some 8% less than at Friday's close.

Still, if the broker has this right, it could prove to be a profitable 'buy the dip' scenario.

As for Ansell, the ASX 200 share was in a trading halt yesterday ahead of reporting on a new acquisition and capital raise.

The company revealed it has entered into a binding agreement to acquire 100% of the assets of United States-based Kimberly-Clark's Personal Protective Equipment (KCPPE) business.

You may not have heard of Kimberly-Clark. But you've likely heard of some of their global brands, like Huggies and diapers and Kleenex tissues.

That announcement was released this morning and looks to be fuelling today's rocketing Ansell share price.

The ASX 200 share reported it has successfully completed a $400 million (US$263 million) fully underwritten institutional share placement at a price of $22.45 per share.

Management said the proceeds will be used to partially fund the acquisition of 100% of the assets that constitute KCPPE from Kimberly-Clark Corporation for US$640 million.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ansell and Elders. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise ~40% to 80%

Brokers are predicting big returns for these top shares. Here's what you need to know.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Broker Notes

6 ASX 200 shares downgraded by brokers this week

Brokers have reduced their ratings on TechnologyOne, Macquarie, 4DMedical, and others this week.

Read more »